- Prison Planet -
Kids to receive untested shots which include ingredient linked to Gulf War Syndrome
Paul Joseph Watson
Friday, July 24, 2009
Around 12,000 U.S. children will be used as guinea pigs for an experimental swine flu vaccine known to contain the dangerous ingredient squalene, which has been directly linked with cases of Gulf War Syndrome and a host of other debilitating diseases.
According to a report in the Oklahoman, 12,000 children nationwide will partake in “fast-tracked studies” to test the side-effects of the untested swine flu vaccine in trials set to begin next month.
“The trials will test the vaccine’s effectiveness and whether or not it has negative side effects in patients,” states the report.
Since less than 100 children in the U.S. die from regular seasonal flu each year, a reasonable estimate would be that around 100 children will die from swine flu over the course of the next year.
So in effect, the authorities will vaccinate millions of children in order to try and prevent 100 deaths. If the mass vaccination program mirrors the previous swine flu outbreak of 1976 then the vaccine is likely to kill more people than the actual virus.
Furthermore, since the swine flu vaccine includes squalene, a dangerous adjuvant that contributed to Gulf War Syndrome cases, there’s little doubt that it will lead to debilitating lifelong diseases far more deadly than the swine flu virus itself for thousands of children if a mass vaccination campaign is conducted.
According to Meryl Nass, M.D., “A novel feature of the two H1N1 vaccines being developed by companies Novartis and GlaxoSmithKline is the addition of squalene-containing adjuvants to boost immunogenicity and dramatically reduce the amount of viral antigen needed. This translates to much faster production of desired vaccine quantities.”
“Research shows that squalene is the experimental anthrax vaccine ingredient that caused devastating autoimmune diseases and deaths for many Gulf War veterans from the US, UK, and Australia, yet it continues in use today and for new vaccines development in labs,” writes Stephen Lendman.
Please read it all!